Ewha Med J.
2021 Oct;44(4):117-121. 10.12771/emj.2021.44.4.117.
Diagnosis and Treatment of Central Precocious Puberty
- Affiliations
-
- 1Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2521820
- DOI: http://doi.org/10.12771/emj.2021.44.4.117
Abstract
- A notable secular trend in early puberty onset has been described over the past few decades. Also, the prevalence and incidence of precocious puberty is increasing not only in Korea, but also around the world. The manifestation of secondary sex characteristics before 8 years in girls and 9 years in boys is defined as precious puberty. The causes of precocious puberty can be classified as gonadotropin releasing hormone (GnRH)-dependent, also known as central precocious puberty (CPP), or GnRH-independent. Evaluation of patient with precocity requires detailed examination of the clinical manifestation, GnRH stimulation test, and imaging of the central nervous system if indicated. The standard treatment for CPP is GnRH agonist, which is beneficial for adequate pubertal development and preservation of final adult height. In this paper, we investigate the diagnosis and adequate treatment of CPP.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Early-life obesity as a risk factor for central precocious puberty – A commentary on "Incidence of central precocious puberty and the role of body mass index in Korea"
- Two Cases of Secondary Central Precocious Puberty in Boys with Congenital Adrenal Hyperplasia - before and after Treatment with Corticosteroid
- Central Precocious Puberty Following Treatment of Precocious Pseudo-Puberty Caused by Leydig Cell Tumor: A Pediatric Case and Literature Review
- Etiology and Age Incidence of Precocious Puberty
- A Boy with Adrenocortical Tumor Who Progressed to Central Precocious Puberty after Surgery
